Mendelian
We’re enabling doctors diagnose rare diseases and help patients earlier
Rudy Benfredj, CEO & Cofounder
- Rudy Benfredj
- Fran Garcia
- When we invested
- Seed
- Founded
- 2015
- Partnered
- 2021
- Location
- UK & Europe
- Area
- Personalised medicine
What we do
We are the industry leader in rare disease detection; our mission is to end the diagnostic odyssey for rare disease patients within primary care.
Working closely with the NHS we have developed an effective clinical solution to the highest standard’s that meets the demands of doctors and patients alike.
Our technology is enhancing rare disease detection within primary care,
enabling doctors to identify undiagnosed rare diseases, resulting in faster patient
treatment and reduced clinical burden.
- Quickly & seamlessly integrates with existing primary care clinical systems, scanning patient health records against clinically validated detection algorithms for 100’s of rare diseases.
- Dramatically accelerates rare disease diagnosis within primary care, providing doctors guidance on specialist treatment pathways; improving patient treatment and reducing clinical burden.
- Our technology is currently implemented in over 50 NHS practices and delivering benefit to 1 million patients, with a further roll out to 4 million patients planned for 2021
